Cargando…

Extreme Hypofractionation with SBRT in Localized Prostate Cancer

Prostate cancer is the most commonly diagnosed cancer among men around the world. Radiotherapy is a standard of care treatment option for men with localized prostate cancer. Over the years, radiation delivery modalities have contributed to increased precision of treatment, employing radiobiological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez-Aparicio, Maria Antonia, Valero, Jeannette, Caballero, Begoña, García, Rafael, Hernando-Requejo, Ovidio, Montero, Ángel, Gómez-Iturriaga, Alfonso, Zilli, Thomas, Ost, Piet, López-Campos, Fernando, Couñago, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395496/ https://www.ncbi.nlm.nih.gov/pubmed/34436023 http://dx.doi.org/10.3390/curroncol28040257

Ejemplares similares

Are all prostate cancer patients "fit" for salvage radiotherapy?
por: González-San Segundo, Carmen, et al.
Publicado: (2020)

Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease
por: Henriquez, Ivan, et al.
Publicado: (2021)

Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir
por: Anwar, Mekhail, et al.
Publicado: (2014)

Metastasis-directed therapy: a new standard for oligorecurrent prostate cancer?
por: Zilli, Thomas, et al.
Publicado: (2018)

Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer
por: Montero, Angel, et al.
Publicado: (2023)

Extreme weekly hypofractionation in breast cancer in elderly
por: Blanco Parajón, Sonia, et al.
Publicado: (2020)

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
por: Lara, Pedro C., et al.
Publicado: (2022)

Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT
por: Shen, Junyue, et al.
Publicado: (2021)

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation
por: Ha, Boram, et al.
Publicado: (2019)

Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer
por: Oermann, Eric K, et al.
Publicado: (2011)

Extreme hypofractionation in radiation therapy for patients with early breast cancer: what is the optimal technique?
por: Chin, Yaw Sinn
Publicado: (2022)

Comparing Ultra-hypofractionated Proton versus Photon Therapy in Extremity Soft Tissue Sarcoma
por: Thomas, Rehema, et al.
Publicado: (2023)

Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune Signatures
por: Meireson, Annabel, et al.
Publicado: (2021)

Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)
por: Gladwish, Adam, et al.
Publicado: (2014)

The role and importance of SBRT in prostate cancer
por: Cihan, Yasemin
Publicado: (2018)

Hypofractionation: less is more?
por: Mariam, Neethu Billy Graham, et al.
Publicado: (2021)

PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial
por: De Bruycker, A., et al.
Publicado: (2020)

Elective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 2 Trial
por: Lorton, Orane, et al.
Publicado: (2023)

Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19
por: Martell, Kevin, et al.
Publicado: (2020)

Symptomatic dialysis disequilibrium syndrome after SARS-Cov-2 infection, about a case
por: Motilva, José Lapeña, et al.
Publicado: (2023)

Clinical validation of ring‐mounted halcyon linac for lung SBRT: comparison to SBRT‐dedicated C‐arm linac treatments
por: Pokhrel, Damodar, et al.
Publicado: (2020)

Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases
por: Billiet, Charlotte, et al.
Publicado: (2020)

Neurophobia: why, how much, consequences and solutions
por: Hernando-Requejo, Virgilio
Publicado: (2020)

The impact of technology on the changing practice of lung SBRT
por: Aznar, Marianne Camille, et al.
Publicado: (2018)

The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond
por: Onderdonk, Benjamin E., et al.
Publicado: (2019)

MR‐linac is the best modality for lung SBRT
por: Godley, Andrew, et al.
Publicado: (2019)

Cleaning the dose falloff in lung SBRT plan
por: Desai, Dharmin, et al.
Publicado: (2020)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Moderate hypofractionation for prostate cancer
por: Arcangeli, Stefano, et al.
Publicado: (2017)

Moderate hypofractionation for prostate cancer
por: Lee, W. Robert, et al.
Publicado: (2018)

Hypofractionated Postmastectomy Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)

Better Care Through Hypofractionation
por: Boisvert-Huneault, Christian, et al.
Publicado: (2022)

The Role of Hypofractionation in Proton Therapy
por: Santos, Alexandre, et al.
Publicado: (2022)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
por: Ogawa, Yasutaka, et al.
Publicado: (2018)

Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY)
por: Tubin, Slavisa, et al.
Publicado: (2020)

Lung Adenocarcinoma during Pregnancy: 11-Year Follow-Up
por: Acosta Rojas, Angel, et al.
Publicado: (2020)

Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer
por: Lazo, Antonio, et al.
Publicado: (2022)

Neoadjuvant Hypofractionated Radiotherapy and Chemotherapy in High-Grade Extremity Soft Tissue Sarcomas: Phase 2 Clinical Trial Protocol
por: Spencer, Ranyell MSB, et al.
Publicado: (2017)

Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator
por: den Hartogh, Mariska D., et al.
Publicado: (2019)

Acute toxicities after extremely hypofractionated radiotherapy for prostate cancer: lessons from HYPO-RT-PC and PACE-B
por: Juarez, Jesus E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_523ohqd3f2iic8ruejp1eiscmj